• seRNA-NPCm Drives Nasopharyngeal Carcinoma Metastasis

  2026-08-28

  The reference study identifies a carcinogen-responsive super-enhancer RNA, seRNA-NPCm, as a regulator of nasopharyngeal carcinoma metastasis. Its proposed mechanism connects enhancer–promoter looping with an NPM1/c-Myc/NDRG1 transcriptional axis, while functional and patient-sample analyses support the pathway’s biological and prognostic relevance.

• Baicalin for Adult Visual Plasticity Workflows

  2026-08-28

  Baicalin enables a practical adult amblyopia workflow that combines ocular dominance imaging, electrophysiology, and GABAergic mechanism testing. Its DMSO-compatible formulation also supports carefully separated cancer research applications involving oxidative stress and metastatic signaling.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-27

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to AXL, with shorter and N-terminally truncated peptides showing particularly strong effects. The work connects renin–angiotensin system peptide processing with viral receptor biology, while also emphasizing that the evidence is currently based on biochemical binding assays rather than infection or clinical studies.

• Entecavir: From Potency to HBV Insight

  2026-08-27

  Entecavir, also known as BMS200475, is more than a nanomolar HBV polymerase inhibitor. This article explains how mechanism, resistance, cccDNA biology, and clinical context should shape translational HBV assay design and interpretation.

• Prednisolone: GR Signaling Beyond Steroid Assays

  2026-08-26

  Prednisolone is a synthetic glucocorticoid for dissecting receptor-driven inflammation modulation and cellular response to corticosteroids. This article separates established Prednisolone pharmacology from emerging ERAD-based protein degradation, helping researchers design interpretable cross-domain assays.

• Imatinib Hydrochloride Research Workflows

  2026-08-26

  Build reproducible kinase-inhibition assays around Imatinib hydrochloride, from DMSO stock handling to phospho-signaling validation. The workflow separates direct v-Abl, c-Kit, and PDGFR blockade from downstream effects, while extending a recent kinase–phosphatase conformational insight into practical cancer research.

• Dihydrotestosterone (DHT): Mechanism and Research Use

  2026-08-25

  Dihydrotestosterone (DHT) is an endogenous androgen and potent androgen receptor agonist used to study transcriptional signaling, cancer biology, neuromuscular disease, and muscle physiology. Product data describe DHT-driven EGFR, ERBB2, AKT, and ERK1/2 signaling in androgen receptor-positive bladder cancer models, while separate mouse data report functional benefits in SOD1-G93A ALS mice.

• Fluorouracil: From DNA Stress to Assay Design

  2026-08-25

  Fluorouracil and 5-Fluorouracil connect thymidylate synthase inhibition with measurable DNA replication stress. This article translates product benchmarks and SMC2/SMC4 breast cancer findings into a more rigorous framework for selecting viability, migration, and mechanistic endpoints.

• High-Throughput BBB Modeling with Lysosomal Correction

  2026-08-24

  This 2025 Drug Delivery study develops a Transwell blood-brain barrier surrogate based on LLC-PK1-MOCK and LLC-PK1-MDR1 cells, combining permeability measurements with correction for lysosomal drug trapping. Its comparison with in vivo unbound brain distribution supports rapid CNS compound triage while clarifying why intracellular sequestration must be separated from true barrier transport.

• Idoxuridine Workflows for Reliable Antiviral Assays

  2026-08-24

  This scenario-driven guide explains how Idoxuridine, SKU B1773, can be incorporated into viral DNA synthesis, proliferation, and cytotoxicity workflows without confusing antiviral activity with nonspecific cell injury. It covers solvent controls, storage, orthogonal readouts, interpretation, and practical supplier-selection criteria.

• Ionomycin Calcium Salt: A Calcium-Signaling Lens

  2026-08-23

  Ionomycin calcium salt is a calcium ionophore for resolving how intracellular Ca2+ dynamics shape secretion, protein synthesis, and apoptosis. This article presents an assay-interpretation framework that connects calcium perturbation with biomarker-guided cancer research without overstating therapeutic conclusions.

• ABT-263 (Navitoclax) Workflow Guide

  2026-08-22

  ABT-263 (Navitoclax) gives researchers a direct way to probe Bcl-2-family control of mitochondrial apoptosis, senescent-cell clearance, and treatment sensitivity. This guide connects cell-based apoptosis assays with the reference study’s plasma-dilution findings while emphasizing controls, assay selection, and interpretation limits.

• Toremifene vs Tamoxifen in Advanced Breast Cancer

  2026-08-21

  This Cochrane review synthesized randomized evidence comparing two endocrine therapies for advanced breast cancer and found no clear efficacy advantage for toremifene over tamoxifen. Its main contribution is a structured head-to-head assessment of tumor response, progression, survival, and selected adverse events, while also illustrating the limits of applying class-level SERM evidence to other research settings.

• Palonosetron for Chemotherapy-Induced Nausea and Vomiting

  2026-08-20

  Ruhlmann and Herrstedt review how palonosetron’s long half-life, high 5-HT3-receptor affinity, and allosteric binding may improve control of chemotherapy-induced nausea and vomiting. The paper’s central contribution is its comparison of pharmacologic distinctions with clinical evidence, emphasizing delayed emesis, nausea assessment, tolerability, and the need to interpret antiemetic benefit within combination regimens.

• Pepstatin A: Aspartic Protease Inhibitor Guide

  2026-08-20

  Pepstatin A is a pentapeptide aspartic protease inhibitor used to suppress pepsin, renin, HIV protease, and cathepsin D activity. Its defined target profile supports viral protein processing research, osteoclast differentiation inhibition, and enzyme assays, but it should not be treated as a universal cathepsin or necroptosis inhibitor.

8520 records 1/568 page Next 12345 下5页 Last page